Table 2.
PSA timeline
| Day | FDA | EMA |
|---|---|---|
| Anytime |
Sponsor submits request for PSA to FDA and EMA Agencies decline no PSA Agencies accept Sponsor begins drafting meeting package according to SAWP procedures |
|
| Varies | Meeting Package Submission and Validation Phase; Option for preparatory meeting with EMA according to SAWP procedures | |
| 0 | EMA validates meeting package; FDA receives validated meeting package; Procedure begins | |
| 15–25 | FDA internal meeting | EMA SAWP internal discussion |
| 30–34 | FDA sends Preliminary Comments to EMA | EMA sends List of Issues to FDA |
| 35 | Bilateral FDA/EMA meeting | |
| 65 | Trilateral Sponsor/FDA/EMA meeting | |
| 75 to 95 | FDA issues final meeting minutes (30 days after trilateral) |
EMA issues final advice letter (10 days after trilateral) |